Improve Detection and Management of Gestational Diabetes Through the Primary Health Care Level in Morocco
Améliorer la Detection et la Prise en Charge du diabète Gestationnel au Niveau Des établissements de Soins de santé Primaires au Maroc
1 other identifier
interventional
215
1 country
1
Brief Summary
A situational analysis on gestational diabetes conducted in 2015 in two districts in Morocco revealed difficulties in accessing screening for gestational diabetes (GDM) and delays in receiving appropriate care. Based on the results of the situational analysis, the investigators developed this proposal in close collaboration with the Moroccan research group on gestational diabetes composed of representatives of the Ministry of Health, researchers, members of professional organizations and specialists in the domains of endocrinology, gynecology, neonatal health and nutrition. The investigators opted for an hybrid implementation effectiveness trial to evaluate both clinical effectiveness of the proposed screening and initial management strategy and its implementation at the first level of care. The objectives of this study are thus to evaluate the feasibility of a decentralized strategy of screening for GDM and the initialization of GDM treatment already through the primary level of care and to assess its potential for scaling-up. Specific objectives of this study are to augment universal access to screening and management of gestational diabetes and to increase the competencies of health care providers at first level health care facilities to detect, start initial treatment and to improve follow-up of affected women. By comparing active screening and treatment initiation through first line health facilities with the existing practices, the investigators would like to explore the effect of the new model on maternal and newborn outcomes such as weight gain in pregnancy, occurrence of delivery complications and birth weight. The investigators will further assess the acceptability of screening and initial management of GDM through first line health services by health care providers and by pregnant women diagnosed with GDM and the impact of two different screening approaches on the lifestyle of affected mothers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 14, 2016
CompletedFirst Submitted
Initial submission to the registry
November 22, 2016
CompletedFirst Posted
Study publicly available on registry
December 2, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 12, 2018
CompletedMarch 1, 2018
February 1, 2018
1.1 years
November 22, 2016
February 28, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Macrosomia
Difference in birth weight of babies of mothers detected with GDM in the different arms
within 6 months after being diagnosed with GDM
Secondary Outcomes (2)
Acceptance of GDM screening
within 6 months after being diagnosed with GDM
Lifestyle impact of GDM
within 6 months after being diagnosed with GDM
Study Arms (2)
Decentralized GDM screening and initial management
EXPERIMENTALIn this arm, the intervention consists of screening all pregnant women for GDM using the nationally recommended oral glucose tolerance test that will take place during antenatal care consultations in 10 randomly selected primary health care facilities. Overall, 80 women who are diagnosed with GDM and who consent to participate will receive initial nutritional counseling and will be closely followed up.
Standard GDM screening and management practice
NO INTERVENTIONIn this arm, screening for GDM will follow standard practice. 80 women diagnosed with GDM in 10 randomly selected primary health care facilities and who consent to participate will be followed up.
Interventions
Screening for GDM and initialization of nutritional therapy at the first level of care
Eligibility Criteria
You may qualify if:
- Pregnant women attending ANC (screening)
- Women diagnosed with GDM (follow-up)
- Informed consent
You may not qualify if:
- Pregnant women with pre-existing diabetes type 1 or 2
- No informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
20 facilities in Marrakech and Al Haouz - Region Marrakech-Safi
Marrakesh, 40000, Morocco
Related Publications (3)
Utz B, Assarag B, Lekhal T, Van Damme W, De Brouwere V. Implementation of a new program of gestational diabetes screening and management in Morocco: a qualitative exploration of health workers' perceptions. BMC Pregnancy Childbirth. 2020 May 24;20(1):315. doi: 10.1186/s12884-020-02979-9.
PMID: 32448233DERIVEDUtz B, Assarag B, Smekens T, Ennassiri H, Lekhal T, El Ansari N, Fakhir B, Barkat A, Essolbi A, De Brouwere V. Detection and initial management of gestational diabetes through primary health care services in Morocco: An effectiveness-implementation trial. PLoS One. 2018 Dec 28;13(12):e0209322. doi: 10.1371/journal.pone.0209322. eCollection 2018.
PMID: 30592751DERIVEDUtz B, Assarag B, Essolbi A, Barkat A, El Ansari N, Fakhir B, Delamou A, De Brouwere V. Improving detection and initial management of gestational diabetes through the primary level of care in Morocco: protocol for a cluster randomized controlled trial. Reprod Health. 2017 Jun 19;14(1):75. doi: 10.1186/s12978-017-0336-z.
PMID: 28629468DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Bouchra Assarag, MD
Ecole Nationale de Santé Publique, Rabat, Morocco
- PRINCIPAL INVESTIGATOR
Bettina Utz, MD
Institute of Tropical Medicine, Antwerp, Belgium
- STUDY DIRECTOR
Vincent De Brouwere, MD
Institute of Tropical Medicine, Antwerp, Belgium
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2016
First Posted
December 2, 2016
Study Start
November 14, 2016
Primary Completion
December 15, 2017
Study Completion
February 12, 2018
Last Updated
March 1, 2018
Record last verified: 2018-02